Company attributes
B2X
Pitchbook URL
Legal Name
PACT Pharma, Inc.
Legal classification
Number of Employees (Ranges)
51 – 200
Email Address
info@pactpharma.com
Phone Number
+16505979500
Full Address
2 Corporate Dr South San Francisco, CA, 94080-7047 United States
Founded Date
2016
Total Funding Amount (USD)
200,000,000
Latest Funding Round Date
January 11, 2020
Latest Funding Type
Patents Assigned (Count)
5
Technologies Used
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
75,000,000
The technology in development at PACT Pharma aims to reprogram immune systems to target and eradicate the cancer. PACT Pharma is engineering synthetic tumor-infiltrating lymphocytes (synthetic TILs), tailored for each patient's cancer with efficient turnaround in manufacturing from tumor biopsy to re-infusion of autologous synthetic TILs back into the patient.
PACT Pharma raised $95 million in Series B financing. Alphabet Inc.'s venture arm GV led the round, with participation from Invus Group, Canaan Partners, Casdin Capital, Wu Capital and other undisclosed investors.
Timeline
No Timeline data yet.
